Skip to main content

Table 1 Urinary levels of gene expression for the studied genes in kidney transplant patients.

From: Evaluation of Gene Panel mRNAs in Urine Samples of Kidney Transplant Recipients as a Non-invasive Tool of Graft Function

 

< 6 months post-transplantation

> 6 months post-transplantation

P value

AGT

  

0.08

N

31

64

 

Mean

5.23

10.09

 

Median

1

5.28

 

Std. Dev.

11.15

13

 

(Minimum, Maximum)

(0.0005, 55.7)

(0.054, 64.0)

 

EGFR

  

0.16

N

31

64

 

Mean

6.38

10.63

 

Median

1.62

5.28

 

Std. Dev.

14.19

13.58

 

(Minimum, Maximum)

(0.287, 68.594)

(0.054, 64.0)

 

IFN-γ

  

0.42a

N

28

63

 

Mean

6.15

11.49

 

Median

1.16

1

 

Std. Dev.

20.89

42.46

 

(Minimum, Maximum)

(0.011, 111.43)

(0.002, 315.17)

 

IL10

  

0.005a

N

30

64

 

Mean

0.86

18.61

 

Median

0.13

3.59

 

Std. Dev.

2.71

48.83

 

(Minimum, Maximum)

(0.001, 14.93)

(0.041, 337.79)

 

TGF-β1

  

0.26a

N

31

64

 

Mean

1.37

11.15

 

Median

0.5

1.52

 

Std. Dev.

2.73

68.37

 

(Minimum, Maximum)

(0.006, 14.93)

(0.134, 548.748)

 

TSP-1

  

0.99a

N

31

64

 

Mean

5.48

5.52

 

Median

0.47

1.036

 

Std. Dev.

26.29

15.51

 

(Minimum, Maximum)

(0.033, 147.033)

(0.001, 103.968)

 
  1. aIndicates a significant difference between variances noted via F-test; Satterthwaite’s approximation to the degrees of freedom used in t-test.